FDA extends comment time on rule for US imports:
This article was originally published in Clinica
Executive Summary
The FDA has reopened the comment period for a further 60 days on its proposed rule requiring foreign establishments whose food, drug and device products are imported into the US to register with the FDA. The Canadian government said the proposed requirement could present significant cost and compliance burdens to its small and medium-sized companies so it needed more time to prepare comments and ensure that its firms are aware of the proposal. The comment period initially ended on July 28 it will now close on October 8.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.